TAK-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-101, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet [Phase 2]